Efstathios Kastritis
Researcher Next ID · RN-023975
Researcher · Medicine
Matsumoto, Greece
- Works count
- 1,161
- Citation count
- 41,633
- H-index
- 84
- i10-index
- 408
Research interests
Publications
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Trends in Molecular Medicine · 2022 · 10.1016/j.molmed.2022.04.007
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Journal of Biomedical Science · 2021 · 10.1186/s12929-020-00703-5
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
New England Journal of Medicine · 2021 · 10.1056/nejmoa2028631
Emerging treatment strategies for COVID-19 infection
Clinical and Experimental Medicine · 2020 · 10.1007/s10238-020-00671-y
Organ-specific manifestations of COVID-19 infection
Clinical and Experimental Medicine · 2020 · 10.1007/s10238-020-00648-x
Hematological findings and complications of COVID ‐19
American Journal of Hematology · 2020 · https://doi.org/10.1002/ajh.25829
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Blood Cancer Journal · 2020 · 10.1038/s41408-020-00366-3
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
Nature Reviews Nephrology · 2018 · 10.1038/s41581-018-0077-4
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
New England Journal of Medicine · 2018 · 10.1056/nejmoa1802917
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Leukemia · 2017 · 10.1038/leu.2017.138
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology · 2016 · 10.1200/jco.2015.65.0044
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30206-6
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Haematologica · 2015 · https://doi.org/10.3324/haematol.2014.117176
Diagnosis of monoclonal gammopathy of renal significance
Kidney International · 2015 · 10.1038/ki.2014.408
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70442-5
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
Blood · 2013 · 10.1182/blood-2012-12-473066
How I treat monoclonal gammopathy of renal significance (MGRS)
Blood · 2013 · 10.1182/blood-2013-05-495929
Response assessment in W aldenström macroglobulinaemia: update from the VI th I nternational W orkshop
British Journal of Haematology · 2012 · 10.1111/bjh.12102
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.37.7614
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Cell · 2011 · https://doi.org/10.1016/j.cell.2011.08.017
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.23.8220
Pathogenesis and treatment of renal failure in multiple myeloma
Leukemia · 2008 · 10.1038/leu.2008.131
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
Annals of Oncology · 2008 · 10.1093/annonc/mdn554
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
PubMed · 2006
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.02.8670
Current projects
No projects listed.